Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-09-19

Clinical Trial Update: Ibuprofen and Renal Function in Premature Infants [Phase 4]

View source ↗

Summary

Phase 4 trial completed evaluating ibuprofen for patent ductus arteriosus closure in premature infants and its effects on renal function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Maternite Regionale Universitaire | Conditions: Premature Infants, Patent Ductus Arteriosus | Phase 4 | Status: COMPLETED